The effectiveness of different therapeutic managements in West Syndrome
DOI:
https://doi.org/10.33448/rsd-v13i11.47426Keywords:
West syndrome; Treatment; Medication.Abstract
West Syndrome (WS) is an epileptic encephalopathy that manifests itself in children, depending on age. It is characteristic of infantile spasms that can occur in flexion, extension, or mixed pattern. In addition to these contractions, affected individuals generally experience delayed neuropsychomotor development. Taken together, the electroencephalogram (EEG) of the patients reveals a specific interictal pattern known as hypsarrhythmia, which is an important marker for diagnosing the syndrome. Since its discovery, there has been intense debate about the most effective treatment options for WS. Adrenocorticotropic hormones, corticosteroids, valproic acid and antiepileptic drugs, such as vigabatrin, are some of the most frequently used therapeutic approaches. This present study aims to contribute to research on the best treatment strategies for West Syndrome, based on a careful analysis of 18 articles selected from the scientific platforms Scientific SciELO, PubMed and LILACS.
References
Acevedo, K., Leiva, J. I., Ramos, B., Bravo, S., Skorin, I., & Ardila, S. (2019). Efectos Adversos del Tratamiento con Vigabatrina en Síndrome de West: reporte de 2 casos. Rev. chil. psiquiatr. neurol. infanc. adolesc.(Impr.), 42-50. https://pesquisa.bvsalud.org/portal/resource/pt/biblio-1412204
Antoniuk, S. A., Bruck, I., Spessatto, A., Halick, S. M., Bruin, L. R. D., Meister, E. & Paola, D. D. (2000). Síndrome de West: evolução clínica e eletroencefalográfica de 70 pacientes e resposta ao tratamento com hormônio adrenocorticotrófico, prednisona, vigabatrina, nitrazepam e ácido valpróico. Arquivos de Neuro-Psiquiatria, 58 (3A), 683–90. https://doi.org/10.1590/S0004-282X2000000400014
Batista, B. H. B., & Nunes, M. L. (2002). Síndrome de West: definição, fisiopatologia, critérios, diagnósticos e tratamento. Rev. Med. PUCRS, 232–237. https://pesquisa.bvsalud.org/portal/resource/pt/lil-360276
Cavalcante, L. T. C. & Oliveira, A. A. S. (2020). Métodos de revisão bibliográfica nos estudos científicos. Psicol. Rev. 26(1). https://doi.org/10.5752/P.1678-9563.2020v26n1p82-100
Children’s, A., & Appendino, J. I. (2019). Encefalopatías epilépticas determinadas genéticamente. Medicina (B. Aires), 42–47. https://pesquisa.bvsalud.org/portal/resource/pt/biblio-1040549
Fernanda, & Alfredo, J. (2018). Síndrome de West. Rev. Fac. Cienc. Méd. Univ. Cuenca, 36(2): 70–4. https://pesquisa.bvsalud.org/portal/resource/pt/biblio-998702
Gomes, M. D. C., Garzon, E., & Sakamoto, A. C. (2008). Os 50 anos de uso do hormônio adrenocorticotrófico (ACTH) no Tratamento da Síndrome de West: revisão de literatura e protocolo da UNIFESP. Journal of Epilepsy and Clinical Neurophysiology, 14, 27–32. https://doi.org/10.1590/S1676-26492008000100007
Henriques-Souza, A. M. M., Junior, A. L., & Laurentino, S. G. (2007). Vigabatrina no tratamento da síndrome de West: avaliação clínica e eletroencefalográfica em 13 pacientes. Arquivos de Neuro-Psiquiatria, 65 (1), 114–149. https://doi.org/10.1590/s0004-282x2007000100029
Kamiyama, M. A., Yoshinaga, L., & Tonholo-Silva, E. R. (1993). Síndrome de West: a propósito de nove casos. Arquivos de Neuro-Psiquiatria, 51(3), 352-357. https://doi.org/10.1590/S0004-282X1993000300011
Linares-Espinós, E., Hernández, V., Domínguez-Escrig, J. L., Fernández-Pello, S., Hevia, V., Mayor, J., Padilla-Fernández, B., & Ribal, M. J. (2018). Methodology of a systematic review. Actas Urologicas Espanolas, 42(8), 499–506. Science Direct. https://www.sciencedirect.com/science/article/abs/pii/S0210480618300615?via%3Dihub
Matsuura, R., Hamano, S., Kubota, J., Daida, A., Ikemoto, S., Hirata, Y., & Koichihara, R. (2019). Efficacy and safety of pyridoxal in West syndrome: A retrospective study. Brain and Development, 41(5), 413–419. https://doi.org/10.1016/j.braindev.2018.11.010.
Moraes, M. H. P., Montenegro, M. A., Franzon, R. C., Ávila, J. O., & Guerreiro, M. M. (2005). Avaliação da eficácia e tolerabilidade da vigabatrina na síndrome de West. Arquivos de Neuro-Psiquiatria, 63(2b), 469–473. https://doi.org/10.1590/s0004-282x2005000300019.
Pinto, G., & Mendoza, G. (2015). Síndrome de West,experiencia con una serie de casos con acceso al tratamiento de primera línea, en Lima. Rev. Neuro-Psiquiatr. (Impr.), 65–72. https://pesquisa.bvsalud.org/portal/resource/pt/lil-752354.
Rosso, A. L., Nicaretta, D. H., & Mattos, J. P. de. (2011). Diagnóstico e tratamento atual das mioclonias: revisão da literatura. Rev. Bras. Neurol, 7–15. https://pesquisa.bvsalud.org/portal/resource/pt/lil-621072.
Rother, E. T. (2007). Revisão sistemática x revisão narrativa. Acta paul. enferm. 20(2). https://doi.org/10.1590/S0103-21002007000200001.
Rotta, N. T., Silva, A. R. da, Ohlweiler, L., & Riesgo, R. (2003). Vigabarina no tratamento da epilepsia de difícil controle em pacientes com síndrome de West e esclerose tuberosa. Arquivos de Neuro-Psiquiatria, 61(4), 988–990. https://doi.org/10.1590/s0004-282x2003000600018.
Sampaio, Maria, Ribeiro, M., Seguti, L., Mara, S., Montenegro, M. A., Antoniuk, S., & Luíza, M. (2023). Brazilian experts’ consensus on the treatment of infantile epileptic spasm syndrome in infants. Arq Neuropsiquiatr, 844–856.
Sampaio, R. F., & Mancini, M. C. (2007). Estudos de revisão sistemática: Um guia para síntese criteriosa da evidência científica. Revista Brasileira de Fisioterapia, 11(1), 83–89. https://doi.org/10.1590/s1413-35552007000100013.
Shumiloff, N. A., Lam, W. M., & Manasco, K. B. (2013). Adrenocorticotropic hormone for the treatment of West Syndrome in children. The Annals of Pharmacotherapy, 47(5), 744–754. https://doi.org/10.1345/aph.1R535.
Tribunal de Justiça do Estado de Minas Gerais. (nd). Visão geral dos tratamentos e medicamentos para epilepsia: Sabril, Tegretol, Valpakine, Vinocard Q10 . BDJur. https ://bd.tj.só.br/s/api /núcleo /bit/0ef740c1 -8dc8 -4-bbc6 -b/contente.
Vega, J., & Acevedo, K. (2022). Vigabatrina comparado con hormona adrenocorticotrópica para el tratamiento de espasmos infantiles y Síndrome de West. Rev. Chil. Psiquiatr. Neurol. Infanc. Adolesc. (Impr.), 23–33. https://pesquisa.bvsalud.org/portal/resource/pt/biblio-1392318.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Vitória Carvalho de Brito; Leonardo Valença Varejão Albuquerque; Mariana Ferraz Macieira; Sofia Holmes Carvalho; Victória de Luna Falcão; Vinicius Alves Thuler
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
